Big bull's holdings cross Rs 7,200 crore (Rs 72 billion).
Genuine investments identified so far is Rs.1.08 cr out of around Rs 24,000 cr.
On the investor side, we realised most of the funds have foreign capital, thus closing down the opportunity to the Indian investor.
On the lines of Shariah-compliant products, intermediaries ask exchanges to consider investment benchmark.
List of disappearing entities could see additions, for first time in 20 years.
The 'T' group stocks refers to stocks which are only allowed to be traded on a delivery-basis.
The Securities and Exchange Board of India's (Sebi's) planned research analyst regulations will also apply to proxy advisory services which provide advice on corporate governance and issue voting recommendations to institutional shareholders regarding company resolutions.
It pegs the value of these companies at Rs 2 lakh crore (Rs 2 trillion).
Portfolio investors based out of the US and other countries with which India does not have favourable tax treaties will have to pay a 15 per cent tax on their derivative transactions, after the Budget decided to classify income from all foreign portfolio investment as capital gains.
Operational income not covering even their interest expenses, finds study; analysts say if economy turns around, new equity issuances an option
.jpg)
Firms with low promoter holding may get to buy shares from secondary market.
Since April 1, promoters of Jaiprakash Associates have released more than 225 million Jaiprakash Power Ventures shares (valued at Rs 425 crore) pledged with lenders.
Jaipuria has not specified the amount he is looking to raise, but says this is the right time to tap the capital markets.
This comes in the wake of allegations of financial irregularities by the erstwhile management led by Harish Moolchandani.
Reserve requirements, mandatory investment in G-secs under Companies Act may slow lending for HNI investment in IPOs.
While the two high-profile exits in pharmaceutical and telecom have raised concerns over regulatory hassles in the country, Japanese investors are still keen to tap into India's consumer growth story and many more merger and acquisition deals are in the offing in this space.
Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is complete.
Private equity players believe it to be lucrative to invest in designer labels.
At present,Satish Khanna he is associated with companies such as Fullife Healthcare, Kagashin, Hi Tech, Provivi, Status Quo and Concord.
Could address the concerns over Companies Act provision on the issue
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances